Neuroone Medical Technologies Corp Total Liabilities

Latest as of March 2026: $2.49 Million USD

Neuroone Medical Technologies Corp total liabilities. Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) has total liabilities worth $2.49 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Neuroone Medical Technologies Corp's assets to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Neuroone Medical Technologies Corp (2010–2025)

Total liabilities of Neuroone Medical Technologies Corp from 2010 to 2025. This chart illustrates how Neuroone Medical Technologies Corp's total liabilities have evolved over time, based on quarterly financial data.

Neuroone Medical Technologies Corp Competitors by Total Liabilities

The table below lists competitors of Neuroone Medical Technologies Corp ranked by their total liabilities.

Company Country Total Liabilities
Mobotix AG
F:MBQ
Germany €61.63 Million
Polar Capital Holdings plc
LSE:POLR
UK GBX97.30 Million
Peako Ltd
AU:PKO
Australia AU$127.87K
Kamdar Group (Malaysia) Bhd
KLSE:8672
Malaysia RM49.23 Million
Vitura Health Ltd
AU:VIT
Australia AU$31.49 Million
Zaklady Urzadzen Kotlowych Staporkow SA
WAR:ZUK
Poland zł17.94 Million
Lima Dua Lima Tiga PT
JK:LUCY
Indonesia Rp47.91 Billion
American Manganese Inc
V:AMY
Canada CA$4.45 Million

Liability Composition Analysis (2010–2025)

This chart breaks down Neuroone Medical Technologies Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Neuroone Medical Technologies Corp.

Liquidity & Leverage Metrics

Neuroone Medical Technologies Corp Total Liabilities Ratios Explained

Neuroone Medical Technologies Corp total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 4.37 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.46 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.32 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neuroone Medical Technologies Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neuroone Medical Technologies Corp (2010–2025)

The table below shows the annual total liabilities of Neuroone Medical Technologies Corp from 2010 to 2025.

Year Total Liabilities Change
2025-09-30 $3.71 Million -18.36%
2024-09-30 $4.55 Million +146.11%
2023-09-30 $1.85 Million -42.58%
2022-09-30 $3.22 Million +132.43%
2021-09-30 $1.38 Million -48.60%
2020-09-30 $2.69 Million +52.16%
2019-09-30 $1.77 Million -61.64%
2018-09-30 $4.61 Million +351.02%
2017-09-30 $1.02 Million +1127.83%
2016-09-30 $83.33K +134.11%
2015-09-30 $35.59K +23.14%
2014-09-30 $28.91K +57.48%
2013-09-30 $18.36K 0.00%
2012-09-30 $18.36K +7.16%
2011-09-30 $17.13K +27.33%
2010-09-30 $13.45K --

About Neuroone Medical Technologies Corp

NASDAQ:NMTC USA Medical Devices
Market Cap
$8.45 Million
Market Cap Rank
#27372 Global
#5683 in USA
Share Price
$0.98
Change (1 day)
+4.84%
52-Week Range
$0.59 - $5.11
All Time High
$26.97
About

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson'… Read more